Cargando…
Use of recombinant human deoxyribonuclease in pediatric intensive care unit – a single-center experience
OBJECTIVE: Dornase alfa (rhDNase) reduces the viscosity of purulent sputum in the lungs. The use in patients with cystic fibrosis (CF) is proven. However, the evidence of its applicability to other conditions is limited. This study aims to present the authors’ experience with the use of rhDNase in n...
Autores principales: | Meireles, Daniel, Fernandes, Sofia Ribeiro, Sarmento, Alzira, Barbosa, Telma, Magalhães, Manuel Ferreira, Ramos, Ana, Fernandes, Paula Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade de Pediatria de São Paulo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432166/ https://www.ncbi.nlm.nih.gov/pubmed/34495270 http://dx.doi.org/10.1590/1984-0462/2022/40/2020169 |
Ejemplares similares
-
Recombinant Human Deoxyribonuclease I
por: Lazarus, Robert A., et al.
Publicado: (2019) -
Structure of acid deoxyribonuclease
por: Varela-Ramirez, Armando, et al.
Publicado: (2017) -
Deoxyribonucleases and Their Applications in Biomedicine
por: Lauková, Lucia, et al.
Publicado: (2020) -
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
por: Pressler, Tacjana
Publicado: (2008) -
Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns
por: Fedakar, Atiye, et al.
Publicado: (2012)